Edgard Torres dos Reis-Neto

ORCID: 0000-0003-0657-4825
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • Systemic Lupus Erythematosus Research
  • Long-Term Effects of COVID-19
  • Dermatological and COVID-19 studies
  • Autoimmune and Inflammatory Disorders Research
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 and Mental Health
  • Systemic Sclerosis and Related Diseases
  • Atherosclerosis and Cardiovascular Diseases
  • Peripheral Neuropathies and Disorders
  • Rheumatoid Arthritis Research and Therapies
  • Renal Diseases and Glomerulopathies
  • Healthcare professionals’ stress and burnout
  • Inflammasome and immune disorders
  • COVID-19 and healthcare impacts
  • Pharmacological Effects of Natural Compounds
  • Parvovirus B19 Infection Studies
  • Musculoskeletal pain and rehabilitation
  • Liver Disease Diagnosis and Treatment
  • Inflammatory Myopathies and Dermatomyositis
  • Salivary Gland Disorders and Functions
  • Vitamin C and Antioxidants Research
  • Healthcare Regulation
  • Immune Cell Function and Interaction
  • Infectious Encephalopathies and Encephalitis

Universidade Federal de São Paulo
2013-2025

ORCID
2023

University Center of Brasília
2022

Hospital São Paulo
2020-2021

Hospital Alemão Oswaldo Cruz
2021

Fundação de Apoio à Universidade Federal de São Paulo
2021

Instituto Barretos de Tecnologia
2020

Hospital das Clínicas da Universidade Federal de Pernambuco
2020

Centro Universitário São Camilo
2015

Objectives To evaluate risk factors associated with unfavourable outcomes: emergency care, hospitalisation, admission to intensive care unit (ICU), mechanical ventilation and death in patients immune-mediated rheumatic disease (IMRD) COVID-19. Methods Analysis of the first 8 weeks observational multicentre prospective cohort study (ReumaCoV Brasil register). Patients IMRD COVID-19 according Ministry Health criteria were classified as eligible for study. Results 334 participants enrolled, a...

10.1136/rmdopen-2020-001461 article EN cc-by-nc RMD Open 2021-01-01
Natália Sarzi Sartori Ketty Lysie Libardi Lira Machado Samira Tatiyama Miyamoto F. Z. Pretti Maria da Penha Gomes Gouvea and 55 more Yasmin Gurtler Pinheiro de Oliveira Vasco Silva Filipe Faé Ana Paula Neves Burian K. Rosemarie Lallemand Tapia Anna Carolina Simões Moulin Luiza Lorenzoni Grillo Paula dos Santos Athayde Helena da Silva Corona Sabrina de Souza Ramos Flávia Maria Matos Melo Campos Peixoto Priscila Dias Cardoso Ribeiro Vanessa Oliveira Magalhães Mariana Freitas de Aguiar Erika Biegelmeyer Cristiane Kayser Alexandre Wagner Silva de Souza Charlles Heldan de Moura Castro Juliana Bühring Sandra Lúcia Euzébio Ribeiro Sérgio Henrique Oliveira dos Santos Clara Pinheiro Martins J. Rodrigues Marcos Mavignier Sousa Dias Bruna Guimarães Dutra Camila Maria Paiva França Telles Samuel Elias Basualto Dias Rodrigo Poubel Vieira de Rezende Kátia Lino Rodrigo Cutrim Gaudio Ana Karla Guedes de Melo Valéria Bezerra da Silva Vítor Alves Cruz Jozélia Rêgo Rejane Maria Rodrigues de Abreu Vieira Adah Sophia Rodrigues Vieira Adriana María Kakehasi Anna Carolina Faria Moreira Gomes Tavares Victória Dornelas Paz Carvalho Renata Henriques de Azevedo Valderílio Feijó Azevedo Olindo Assis Martins-Filho Vanessa Peruhype-Magalhães Andrese Aline Gasparin Vanessa Hax Valéria Valim Gilda Aparecida Ferreira Andréa Teixeira-Carvalho Edgard Torres dos Reis-Neto Emília Inoue Sato Marcelo M. Pinheiro Viviane Angelina de Souza Ricardo Machado Xavier Gecilmara Salviato Pileggi Odirlei André Monticielo

Objective: To evaluate the humoral response to and impact of SARS-CoV-2 vaccination in patients with systemic lupus erythematosus a multicenter cohort design. Methods: Data for this analysis were obtained from Study Safety, Effectiveness Duration Immunity after Vaccination against Patients Immune-Mediated Inflammatory Diseases (SAFER), prospective, multicenter, phase IV, real-world study conducted across different regions Brazil June/2021 March/2024. aged >18 years (SLE) who received any...

10.3390/vaccines13020127 article EN cc-by Vaccines 2025-01-27

Objective. The objective of this study was to evaluate the effect supervised physical exercise on endothelial function, ergospirometric test variables and disease activity in SLE patients. Methods. We conducted a prospective which women with who were available perform allocated group (EG) practise for 1 h three times per week 16 weeks. Those not control (CG). Intervention consisted walking at heart rate corresponding ventilatory threshold obtained from ergospirometry monitored by frequency...

10.1093/rheumatology/ket283 article EN Lara D. Veeken 2013-08-22

Abstract Objectives To compare the impact of COVID-19 on clinical status and psychological distress patients with immune-mediated rheumatic disease (IMRD) caused by SARS-CoV-2 infection that noninfected IMRD controls during a 6-month follow-up period. Methods The ReumaCoV Brazil is longitudinal study designed to follow for 6 months after (patients) compared without (controls). Clinical data, activity measurements current treatments regarding outcomes were evaluated in all patients. Disease...

10.1186/s42358-025-00434-x article EN cc-by Advances in Rheumatology 2025-01-22

Objectives Primary: To validate a previously developed lupus nephritis (LN) histologic class predictor tool (III or IV±(V) vs V). In this instrument, urinary sediment, anti-dsDNA antibody and serum creatinine were variables. Secondary: evaluate its accuracy in different cut levels of red cell count LN patient’s profile that may be useful to guide diagnosis treatment, especially when kidney biopsy is not available. Methods A retrospective, cross-sectional study 196 patients with SLE who...

10.1136/lupus-2025-001538 article EN cc-by-nc-nd Lupus Science & Medicine 2025-01-01

Patients with immune-mediated rheumatic diseases (IMRD) are at increased risk of infections, including significant morbidity and high mortality. Considering the potential for unfavorable outcomes SARS-CoV-2 infection in patients IMRD, several questions were raised regarding impact COVID-19 start pandemic.This paper presents protocol a study that aims to prospectively evaluate IMRD confirmed diagnosis (using criteria provided by Brazilian Ministry Health).The comprised prospective,...

10.2196/24357 article EN cc-by JMIR Research Protocols 2020-11-01

Background Acute exercise increases IL-6, IL-10 and TNF-α levels in healthy subjects. There is no study evaluating the effect of on cytokines level systemic lupus erythematosus (SLE) patients. Objective Our aim was to assess IL-10, IL-6 at baseline after acute physical patients with SLE. Methods In total, 27 female SLE 30 controls were evaluated. Serum soon ergospirometric test measured by ELISA test. Student's t-tests Mann–Whitney used for intra- inter-group comparisons; p values <0.05...

10.1177/0961203313508832 article EN Lupus 2013-10-17

To determine the incidence of positive CMV antigenemia (CMV-Ag) in patients with autoimmune rheumatic diseases (AIRD) and to describe outcomes these patients. From January 2011 December 2014, a total 443 AIRD were enrolled this retrospective analysis. Demographic, clinical laboratory data, current manifestations, organs affected by infection, therapeutic management evaluated. The CMV-Ag was considered when one cell detected at least. requested 70 (15.8%) suspicious infection 24 (34.3%). rate...

10.1186/s42358-019-0061-0 article EN cc-by Advances in Rheumatology 2019-05-14

To evaluate the impact and risk factors associated with an abnormal exercise test (ET) in systemic inflammatory rheumatic disease (SIRD) patients before commencing supervised physical exercise.A total of 235 SIRD were enrolled three controlled clinical trials, including 103 RA, 42 SLE 57 AS patients. The control group consisted 231 healthy, sedentary subjects matched for age, gender BMI. All performed ET, according to Bruce's or Ellestad's protocol. Cardiovascular factors, medications,...

10.1093/rheumatology/kew277 article EN Lara D. Veeken 2016-08-01

Abstract Background There is a lack of information on the role chronic use hydroxychloroquine during SARS-CoV-2 outbreak. Our aim was to compare occurrence COVID-19 between rheumatic disease patients with individuals from same household not taking drug first 8 weeks community viral transmission in Brazil. Methods This baseline cross-sectional analysis part 24-week observational multi-center study involving 22 Brazilian academic outpatient centers. All regarding symptoms, epidemiological,...

10.1186/s42358-021-00217-0 article EN cc-by Advances in Rheumatology 2021-10-07

Objectives to evaluate the main factors associated with mortality and determine life expectancy of SLE patients between 2000 2019 years in Brazil. Methods death data related available Brazilian Unified Health System (SUS) (DATASUS) were evaluated all states. Three groups causes potentially from evaluated: cardiovascular kidney diseases infections. Results The infection disease. Most died 19 50 age. Deaths disease proportionally higher than general population progressive decrease during...

10.1177/09612033241236383 article EN Lupus 2024-02-28
Vítor Alves Cruz Camila Guimarães Jozélia Rêgo Ketty Lysie Libardi Lira Machado Samira Tatiyama Miyamoto and 64 more Ana Paula Neves Burian Laiza Hombre Dias F Pretti Danielle Cristina Filgueira Alves Batista José Geraldo Mill Yasmin Gurtler Pinheiro de Oliveira Carolina Strauss Estevez Gadelha Maria da Penha Gomes Gouveia Anna Carolina Simões Moulin Bárbara Oliveira Souza Laura Aguiar Gabriel Smith Sobral Vieira Luiza Lorenzoni Grillo Marina Deorce de Lima Laís Pizzol Pasti Heitor Filipe Surlo Filipe Faé Isac Ribeiro Moulaz Mariana de Oliveira Macabú Priscila Dias Cardoso Ribeiro Vanessa de Oliveira Magalhães Mariana Freitas de Aguiar Erika Biegelmeyer Flávia Maria Matos Melo Campos Peixoto Cristiane Kayser Alexandre Wagner Silva de Souza Charlles Heldan de Moura Castro Sandra Lúcia Euzébio Ribeiro Camila Maria Paiva França Telles Juliana Bühring Raquel Lima de Lima Sérgio Henrique Oliveira dos Santos Samuel Elias Basualto Dias Natália Seixas de Melo Rosely Holanda da Silva Sanches Antônio Luiz Boechat Natália Sarzi Sartori Vanessa Hax Lucas Denardi Dória Rodrigo Poubel Vieira de Rezende Kátia Lino Natália Rodrigues Querido Fortes Ana Karla Guedes de Melo Tâmara Santos Melo Rejane Maria Rodrigues de Abreu Vieira Adah Sophia Rodrigues Vieira Adriana María Kakehasi Anna Carolina Faria Moreira Gomes Tavares Aline Teixeira de Landa Pollyana Vitoria Thomaz da Costa Valderílio Feijó Azevedo Olindo Assis Martins‐Filho Vanessa Peruhype-Magalhães Marcelo Antônio Amaro Pinheiro Odirlei André Monticielo Edgard Torres dos Reis-Neto Gilda Aparecida Ferreira Viviane Angelina de Souza Andréa Teixeira‐Carvalho Ricardo Machado Xavier Emília Inoue Sato Valéria Valim Gecilmara Salviato Pileggi Nílzio Antônio da Silva

Abstract Background Patients with immune-mediated rheumatic diseases (IMRDs) have been prioritized for COVID-19 vaccination to mitigate the infection severity risks. rheumatoid arthritis (RA) are at a high risk of severe outcomes, especially those under immunosuppression or associated comorbidities. However, few studies assessed safety vaccine in patients RA. Objective To evaluate vaccines against SARS-CoV-2 Methods This data from study “Safety and Efficacy on Vaccine Rheumatic Diseases,”...

10.1186/s42358-024-00397-5 article EN cc-by Advances in Rheumatology 2024-08-12

Breakthrough COVID-19 (occurring in fully vaccinated people) has been described. Data on its characteristics among immune mediated rheumatic disesases (IMRD) patients are scarce. This study describes breakthrough IMRD participating of SAFER-study, a Brazilian multicentric cohort evaluating safety, effectiveness and immunogenicity SARS-Cov-2 vaccines autoimmune diseases. Descriptive analysis binary logistic regression model, to evaluate predictors COVID-19-related hospitalization, were...

10.20944/preprints202408.0111.v1 preprint EN 2024-08-02

Breakthrough COVID-19 (occurring in fully vaccinated people) has been described. Data on its characteristics among immune-mediated rheumatic disease (IMRD) patients are scarce. This study describes breakthrough occurring IMRD participating the SAFER-study, a Brazilian multicentric cohort evaluating safety, effectiveness, and immunogenicity of SARS-CoV-2 vaccines with autoimmune diseases. A descriptive analysis population binary logistic regression model were performed to evaluate predictors...

10.3390/vaccines12091031 article EN cc-by Vaccines 2024-09-09
José A. Gómez‐Puerta Guillermo Pons‐Estel Rosana Quintana Romina Nieto Rosa Maria Serrano Morales and 95 more Guillermina Harvey Daniel Wojdyla Marina Scolnik Carmen Funes Soaje Paula Alba Moreyra Elisa Novatti Fernando Arizpe Guillermo Berbotto Luciana González Lucero Sabrina Porta Nicolás Pérez Anabella M Rodriguez Simone Appenzeller Ana Carolina de Oliveira e Silva Montadon Odirlei André Monticielo Fernando Cavalcanti Francinne Machado Ribeiro Eduardo Ferreira Borba Edgard Torres dos Reis-Neto Óscar Neira José Miguel Chahuán Milena Mimica Gustavo Aroca Gabriel J. Tobón Gloria Vásquez Gerardo Quintana-López Mario José Moreno Álvarez Miguel Ángel Saavedra Mario Pérez Cristóbal Hilda Fragoso-Loyo Luís M. Amezcua‐Guerra Yelitza González-Bello Carlos Abud‐Mendoza Jorge Antonio Esquivel‐Valerio Margarita Duarte I. Acosta-Colman Claudia S Mora-Trujillo Cristina Reátegui-Sokolova Armando A Calvo Quiroz Roberto Muñoz-Louis Ernesto Cairoli Iliana Rosas Martín Rebella Mario H. Cardiel Ignacio García‐De La Torre Luís J. Catoggio Graciela S. Alarcón Bernardo A. Pons‐Estel Guillermo Pons‐Estel José A. Gómez‐Puerta Bernardo A. Pons‐Estel Diana Fernández-Ávila Enrique R. Soriano Nidia Meras Gisela Subilis L. Maurelli Alejandra Babini Carla Gobbi Cintia Otaduy María Haye Salinas Verónica Saurit Valeria Arturi Mercedes García M. Emilia Sattler Julieta A. Daniele M. C. Bertolaccini Verónica Bellomio Marina Micelli Carla Matellán Eduardo Kerzberg María de los Ángeles Gargiulo Graciela Gómez Cecilia Pisoni Micaela Cosatti Lílian Tereza Lavras Costallat Ana Carolina Londe Vitalina de Souza Barbosa Nilzio A Da Silva Andrese Aline Gasparin João Carlos Tavares Brenol Fernando Schmidt Fernandes Ricardo Machado Xavier Ângela Luzia P Duarte Henrique Ataíde Mariz Carolina Albanez A. Cunha Andrade Evandro Mendes Klumb Eloísa Bonfá Luciana Parente Costa Seguro Emily Figueiredo Neves Yuki Lucas Victória de Oliveira Martins Emília Inoue Sato Iris Guerra Alexis Peralta Carolina Llanos Paula I. Burgos

Introduction: After more than 20 years of sustained work, the Latin American Group for Study Lupus (GLADEL) has made a significant number contributions to field lupus, not only in differential role that race/ethnicity plays its course and outcome but also several other studies including beneficial effects using antimalarials lupus patients development consensus guidelines treatment our region. Methods: A new generation “Lupus Investigators” 40 centers throughout America been constituted...

10.1177/0961203320988586 article EN Lupus 2021-01-28

The Latin American population living with lupus lacks reliable and culturally competent health education resources. We describe a Spanish Portuguese online program to educate people about lupus.An extensive network of stakeholders participated in the design, implementation, dissemination, evaluation. Patients rheumatologists selected core topics. Rheumatologists prepared content using evidence-based data. Adaptations were conducted meet audience's literacy cultural values. Social media was...

10.1097/rhu.0000000000001728 article EN cc-by-nc-nd JCR Journal of Clinical Rheumatology 2021-02-17

To compare the correlations of histological class inferences based on clinical manifestations and laboratory tests between rheumatologists nephrologists, to determine associations data with classes develop an instrument that can assist identification in lupus nephritis (LN).Retrospective study medical records 80 systemic erythematosus patients (SLICC criteria classification, 2012) who underwent kidney biopsy 2010 2017. Two two nephrologists received answered questions regarding which was...

10.1177/09612033221143933 article EN Lupus 2022-12-02

COVID-19, caused by the virus SARS-CoV-2, has brought extensive challenges to scientific community in recent months. Several studies have been undertaken an attempt minimize impact of disease worldwide. Although new knowledge quickly disseminated, including viral mechanisms, pathophysiology, and clinical findings, there is a lack information on effective pharmacological management this disease. In vitro shown some benefits related use antimalarials (chloroquine hydroxychloroquine) for...

10.2196/23532 article EN cc-by JMIR Research Protocols 2020-09-08

Myostatin is a protein in the TGF-β family that negatively regulates muscle mass, and follistatin myostatin antagonist.The aim of this study was to measure serum levels idiopathic inflammatory myopathy patients correlate these with strength, fatigue, functional capacity, damage, enzymes.This multicenter cross-sectional including 50 (34 dermatomyositis 16 polymyositis [PM]) 52 healthy individuals (control group [CG]). The disease status evaluated according International Myositis Assessment &...

10.1097/rhu.0000000000001806 article EN JCR Journal of Clinical Rheumatology 2021-11-06

Abstract Background Patients using immunosuppressive drugs may have unfavorable results after infections. However, there is a lack of information regarding COVID-19 in these patients, especially patients with rheumatoid arthritis (RA). Therefore, the aim this study was to evaluate risk factors associated hospitalizations RA. Methods This multicenter, prospective cohort within ReumaCoV Brazil registry and included 489 In context, 269 who tested positive for were compared 220 negative (control...

10.1186/s42358-022-00244-5 article EN cc-by Advances in Rheumatology 2022-05-03

To describe characteristics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in patients with rheumatic immune-mediated inflammatory diseases (IMIDs) from Argentina, Mexico and Brazil, to assess factors associated mortality this population.Data 3 national registries, SAR-COVID (Argentina), CMR-COVID (Mexico), ReumaCoV-Brasil (Brazil), were combined. Adult IMIDs SARS-CoV-2 recruited. Sociodemographic data, comorbidities, IMID clinical treatment, presentation outcomes...

10.1097/rhu.0000000000002038 article EN JCR Journal of Clinical Rheumatology 2023-11-07

Abstract Objectives To compare the impact of COVID-19 on clinical status and psychological condition in patients with immune-mediated rheumatic diseases (IMRD) infected by SARS-CoV-2 IMRD controls not infected, during a 6-month follow-up. Methods The ReumaCoV Brasil is longitudinal study designed to follow-up for 6 months after (cases) compared no (controls). Clinical data, disease activity measurements current treatment regarding IMRD, outcomes were evaluated all patients. Disease was...

10.1101/2024.03.18.24304464 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2024-03-19
Coming Soon ...